150 related articles for article (PubMed ID: 35734087)
1. COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004).
Munoz FM; Posavad CM; Richardson BA; Badell ML; Bunge K; Mulligan MJ; Parameswaran L; Kelly C; Olsen-Chen C; Novak RM; Brady RC; Pasetti M; DeFranco E; Gerber JS; Shriver M; Suthar MS; Moore K; Coler R; Berube B; Kim SH; Piper JM; Miller A; Cardemil C; Neuzil KM; Beigi R;
medRxiv; 2022 Jun; ():. PubMed ID: 35734087
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn.
Munoz FM; Posavad CM; Richardson BA; Badell ML; Bunge KE; Mulligan MJ; Parameswaran L; Kelly CW; Olson-Chen C; Novak RM; Brady RC; Pasetti MF; Defranco EA; Gerber JS; Shriver MC; Suthar MS; Coler RN; Berube BJ; Kim SH; Piper JM; Miller AM; Cardemil CV; Neuzil KM; Beigi RH;
Vaccine; 2023 Aug; 41(36):5296-5303. PubMed ID: 37451878
[TBL] [Abstract][Full Text] [Related]
3. Reduced maternal immunity and vertical transfer of immunity against SARS-CoV-2 variants of concern with COVID-19 exposure or initial vaccination in pregnancy.
Boelig RC; Chaudhury S; Gromowski GD; Mayer S; King J; Aghai ZH; Bergmann-Leitner E
Front Immunol; 2023; 14():1216410. PubMed ID: 37753075
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women.
Atyeo C; Shook LL; Nziza N; Deriso EA; Muir C; Baez AM; Lima RS; Demidkin S; Brigida S; De Guzman RM; Burns MD; Balazs AB; Fasano A; Yonker LM; Gray KJ; Alter G; Edlow AG
Am J Obstet Gynecol; 2023 Jan; 228(1):68.e1-68.e12. PubMed ID: 35868417
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Adverse Reactions, Antibody Patterns, and 12-month Outcomes in the Mother-Infant Dyad After COVID-19 mRNA Vaccination in Pregnancy.
Cassidy AG; Li L; Golan Y; Gay C; Lin CY; Jigmeddagva U; Chidboy MA; Ilala M; Buarpung S; Gonzalez VJ; Basilio E; Duck M; Murtha AP; Wu AHB; Lynch KL; Asiodu IV; Prahl MK; Gaw SL
JAMA Netw Open; 2023 Jul; 6(7):e2323405. PubMed ID: 37450302
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccine induced poor neutralization titers for SARS-CoV-2 omicron variants in maternal and cord blood.
Govindaraj S; Cheedarla N; Cheedarla S; Irby LS; Neish AS; Roback JD; Smith AK; Velu V
Front Immunol; 2023; 14():1211558. PubMed ID: 37465682
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection.
Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Briker SM; Triebwasser JE; Gerber JS; Morris JS; Weirick ME; McAllister CM; Hensley SE; Puopolo KM
JAMA Netw Open; 2022 Nov; 5(11):e2240993. PubMed ID: 36350652
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial.
Tan NH; Geers D; Sablerolles RSG; Rietdijk WJR; Goorhuis A; Postma DF; Visser LG; Bogers S; van Dijk LLA; Gommers L; van Leeuwen LPM; Boerma A; Nijhof SH; van Dort KA; Koopmans MPG; Dalm VASH; Lafeber M; Kootstra NA; Huckriede ALW; van Baarle D; Zaeck LM; GeurtsvanKessel CH; de Vries RD; van der Kuy PHM;
Lancet Infect Dis; 2023 Aug; 23(8):901-913. PubMed ID: 37088096
[TBL] [Abstract][Full Text] [Related]
9. Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Levels After the Pfizer-BioNTech Booster Dose for Coronavirus Disease 2019 (COVID-19) Vaccination During the Second Trimester of Pregnancy.
Kugelman N; Nahshon C; Shaked-Mishan P; Kleifeld S; Cohen N; Sher ML; Zahran H; Barsha H; Assaf W; Shalabna E; Stein N; Lavie O; Kedar R; Riskin-Mashiah S
Obstet Gynecol; 2022 Aug; 140(2):187-193. PubMed ID: 35852268
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Bivalent Booster in Pregnancy: Maternal and Neonatal Antibody Response to Omicron BA.5, BQ.1, BF.7 and XBB.1.5 SARS-CoV-2.
Chen WC; Hu SY; Shen CF; Chuang HY; Ker CR; Shen CJ; Cheng CM
Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766102
[TBL] [Abstract][Full Text] [Related]
11. Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection.
Hyun H; Jang AY; Park H; Heo JY; Seo YB; Nham E; Yoon JG; Seong H; Noh JY; Cheong HJ; Kim WJ; Yoon SY; Seok JH; Kim J; Park MS; Song JY
Front Immunol; 2023; 14():1131229. PubMed ID: 36960070
[TBL] [Abstract][Full Text] [Related]
12. Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study.
Fong CH; Zhang X; Chen LL; Poon RW; Chan BP; Zhao Y; Wong CK; Chan KH; Yuen KY; Hung IF; Yuen JKY; To KK
EBioMedicine; 2023 Feb; 88():104446. PubMed ID: 36706582
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine.
Furukawa K; Tjan LH; Kurahashi Y; Sutandhio S; Nishimura M; Arii J; Mori Y
JAMA Netw Open; 2022 May; 5(5):e2210780. PubMed ID: 35532938
[TBL] [Abstract][Full Text] [Related]
14. Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants.
Cardemil CV; Cao Y; Posavad CM; Badell ML; Bunge K; Mulligan MJ; Parameswaran L; Olson-Chen C; Novak RM; Brady RC; DeFranco E; Gerber JS; Pasetti M; Shriver M; Coler R; Berube B; Suthar MS; Moreno A; Gao F; Richardson BA; Beigi R; Brown E; Neuzil KM; Munoz FM;
Pediatrics; 2024 Mar; 153(3):. PubMed ID: 38332733
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Vaccine Booster Elicits Robust Prolonged Maternal Antibody Responses and Passive Transfer Via The Placenta And Breastmilk.
Marshall NE; Blanton MB; Doratt BM; Malherbe DC; Rincon M; True H; McDonald T; Beauregard C; Adatorwovor R; Messaoudi I
bioRxiv; 2022 Nov; ():. PubMed ID: 36482972
[TBL] [Abstract][Full Text] [Related]
16. Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy.
Kugelman N; Nahshon C; Shaked-Mishan P; Cohen N; Sher ML; Gruber M; Marom I; Zolotarevsky A; Lavie O; Damti A; Zilberlicht A; Bardicef M; Kedar R
JAMA Pediatr; 2022 Mar; 176(3):290-295. PubMed ID: 34932066
[TBL] [Abstract][Full Text] [Related]
17. Third trimester messenger RNA COVID-19 booster vaccination upsurge maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at birth.
Kugelman N; Nahshon C; Shaked-Mishan P; Cohen N; Lahav Sher M; Barsha H; Shalabna E; Zolotarevsky A; Lavie O; Kedar R; Riskin-Mashiah S
Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():148-154. PubMed ID: 35653903
[TBL] [Abstract][Full Text] [Related]
18. Maternal vaccination against COVID-19 and neonatal outcomes during Omicron: INTERCOVID-2022 study.
Barros FC; Gunier RB; Rego A; Sentilhes L; Rauch S; Gandino S; Teji JS; Thornton JG; Kachikis AB; Nieto R; Craik R; Cavoretto PI; Winsey A; Roggero P; Rodriguez GB; Savasi V; Kalafat E; Giuliani F; Fabre M; Benski AC; Coronado-Zarco IA; Livio S; Ostrovska A; Maiz N; Castedo Camacho FR; Peterson A; Deruelle P; Giudice C; Casale RA; Salomon LJ; Soto Conti CP; Prefumo F; Mohamed Elbayoumy EZ; Vale M; Hernández V; Chandler K; Risso M; Marler E; Cáceres DM; Crespo GA; Ernawati E; Lipschuetz M; Ariff S; Takahashi K; Vecchiarelli C; Hubka T; Ikenoue S; Tavchioska G; Bako B; Ayede AI; Eskenazi B; Bhutta ZA; Kennedy SH; Papageorghiou AT; Villar J;
Am J Obstet Gynecol; 2024 Feb; ():. PubMed ID: 38367758
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022.
Canaday DH; Oyebanji OA; White EM; Bosch J; Nugent C; Vishnepolskiy I; Abul Y; Didion EM; Paxitzis A; Sundheimer N; Ragavapuram V; Wilk D; Keresztesy D; Cao Y; St Denis K; McConeghy KW; McDonald LC; Jernigan JA; Mylonakis E; Wilson BM; King CL; Balazs AB; Gravenstein S
MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(4):100-106. PubMed ID: 36701254
[TBL] [Abstract][Full Text] [Related]
20. Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants.
Qu P; Faraone JN; Evans JP; Zheng YM; Carlin C; Lozanski G; Saif LJ; Oltz EM; Gumina RJ; Liu SL
bioRxiv; 2022 Jul; ():. PubMed ID: 35898337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
